High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The human nasal microbiota is highly variable and dynamic often enclosing major pathogens such as Staphylococcus aureus. The potential roles of bacteriocins or other mechanisms allowing certain bacterial clones to prevail in this nutrient-poor habitat have hardly been studied. Of 89 nasal Staphylococcus isolates, unexpectedly, the vast majority (84%) was found to produce antimicrobial substances in particular under habitat-specific stress conditions, such as iron limitation or exposure to hydrogen peroxide. Activity spectra were generally narrow but highly variable with activities against certain nasal members of the Actinobacteria, Proteobacteria, Firmicutes, or several groups of bacteria. Staphylococcus species and many other Firmicutes were insusceptible to most of the compounds. A representative bacteriocin was identified as a nukacin-related peptide whose inactivation reduced the capacity of the producer Staphylococcus epidermidis IVK45 to limit growth of other nasal bacteria. Of note, the bacteriocin genes were found on mobile genetic elements exhibiting signs of extensive horizontal gene transfer and rearrangements. Thus, continuously evolving bacteriocins appear to govern bacterial competition in the human nose and specific bacteriocins may become important agents for eradication of notorious opportunistic pathogens from human microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Bacterial Community Variation in Human Body Habitats Across Space and Time
Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., & Knight, R. (2009) · Science · doi:10.1126/science.1177486 · Cited by 3,231 · cited 1×
“Environmentally exposed microbiomes such as those of the human skin and airways are much more variable than those of the gut [4].”
BackgroundNasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
The Intestinal Microbiome in Early Life: Health and Disease
Arrieta, M.-C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M., & Finlay, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00427 · Cited by 1,024
Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T., & Mizunoe, Y. (2010) · Nature · doi:10.1038/nature09074 · Cited by 991
Targeted versus universal decolonization to prevent ICU infection
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T. R., Lankiewicz, J., Gombosev, A., Terpstra, L., Hartford, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207290 · Cited by 795 · cited 1×
“aureus with the antibiotic mupirocin is a valuable strategy to reduce the risk of endogenous infections in immunocompromised patients [19, 20].”
BackgroundVariability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis
Bogaert, D., Keijser, B., Huse, S., Rossen, J., Veenhoven, R., van Gils, E., Bruin, J., Montijn, R., Bonten, M., & Sanders, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017035 · Cited by 454
The Human Nasal Microbiota and Staphylococcus aureus Carriage
Frank, D. N., Feazel, L. M., Bessesen, M. T., Price, C. S., Janoff, E. N., & Pace, N. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010598 · Cited by 422
Yan, M., Pamp, S. J., Fukuyama, J., Hwang, P. H., Cho, D.-Y., Holmes, S., & Relman, D. A. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.005 · Cited by 351 · cited 1×
“It is interesting to note that nasal bacteria do not only inhibit each other but, in certain instances, appear also to depend on each other and support each other’s growth [45].”
Staphylococcus aureus and the ecology of the nasal microbiome
Liu, C. M., Price, L. B., Hungate, B. A., Abraham, A. G., Larsen, L. A., Christensen, K., Stegger, M., Skov, R., & Andersen, P. S. (2015) · Science Advances · doi:10.1126/sciadv.1400216 · Cited by 253
Cited by
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
The microbiota of the respiratory tract: gatekeeper to respiratory health
Man, W. H., de Steenhuijsen Piters, W. A. A., & Bogaert, D. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.14 · Cited by 1,384
“It could be postulated that, especially in early life, the human host may nourish and promote specific members of the microbiota, such as S. aureus, to benefit from the wide range of antimicrobial molecules that it produces; this could aid the human host in its defence against invading pathogens 96 .”
BackgroundEscapa, I. F., Chen, T., Huang, Y., Gajare, P., Dewhirst, F. E., & Lemon, K. P. (2018) · mSystems · doi:10.1128/msystems.00187-18 · Cited by 590
Microbiota-mediated colonization resistance: mechanisms and regulation
Caballero-Flores, G., Pickard, J. M., & Núñez, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00833-7 · Cited by 474
The microbiome of the upper respiratory tract in health and disease
Kumpitsch, C., Koskinen, K., Schöpf, V., & Moissl-Eichinger, C. (2019) · BMC Biology · doi:10.1186/s12915-019-0703-z · Cited by 465
The microbiome-shaping roles of bacteriocins
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H., & Peschel, A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00569-w · Cited by 395
Self-citationThe commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota
Krismer, B., Weidenmaier, C., Zipperer, A., & Peschel, A. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.104 · Cited by 375
Self-citationBacterial antagonism in host-associated microbial communities
García-Bayona, L., & Comstock, L. E. (2018) · Science · doi:10.1126/science.aat2456 · Cited by 373
Staphylococcus epidermidis and its dual lifestyle in skin health and infection
Severn, M. M., & Horswill, A. R. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00780-3 · Cited by 355
Commensal Staphylococci Influence Staphylococcus aureus Skin Colonization and Disease
Parlet, C. P., Brown, M. M., & Horswill, A. R. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.01.008 · Cited by 276
Commensal Bacteria: An Emerging Player in Defense Against Respiratory Pathogens
Khan, R., Petersen, F. C., & Shekhar, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01203 · Cited by 159
“The well-documented mechanism by which commensal bacteria can directly inhibit the pathogen growth and compete with them is the production of ribosomally produced antimicrobials called bacteriocins (71, 72).”
BackgroundBacteriocin production: A relatively unharnessed probiotic trait?
Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C., & Cotter, P. D. (2016) · F1000Research · doi:10.12688/f1000research.9615.1 · Cited by 141
Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem
Chen, H., Zhao, Q., Zhong, Q., Duan, C., Krutmann, J., Wang, J., & Xia, J. (2022) · Phenomics · doi:10.1007/s43657-022-00073-y · Cited by 79
Krauss, S., Harbig, T. A., Rapp, J., Schaefle, T., Franz-Wachtel, M., Reetz, L., Elsherbini, A. M. A., Macek, B., Grond, S., Link, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03176-22 · Cited by 15
Self-citation
Metadata
- Authors
- Janek, D., Zipperer, A., Kulik, A., Krismer, B., & Peschel, A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-08-04
- Volume
- 12
- Issue
- 8
- Pages
- e1005812
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2486460933
- Cited by
- 157
- References
- 15
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.